Literature DB >> 20137403

[The expression of chemokine-like factor 1 in human atherosclerotic plaques].

Yang Jiao1, Chen-yang Shen, Xiao-ming Zhang.   

Abstract

OBJECTIVE: To evaluate the difference of the expression level of chemokine-like factor 1 (CKLF1) mRNA and protein between human atherosclerotic plaques and normal arteries.
METHODS: Real-time quantitative PCR was performed with experimental group (24 cases of atherosclerotic plaques) specimens and control group (25 cases of normal arteries) specimens. Serial microscopic sections were used for immunohistochemistry with CKLF1 antibody in 17 experimental group specimens and 10 control group specimens.
RESULTS: The endothelial cell, vascular smooth muscle cell (VSMC) and macrophage were CKLF1 positive expression cells in atherosclerotic plaques. There was a foundational expression of CKLF1 mRNA in control group (RQ(Median) = 2.4), and the expression of CKLF1 mRNA in experimental group is up-regulated significantly (RQ(Median) = 132.2, P < 0.05). The VSMC positive expression rate of CKLF1 protein was 100% in experimental group and 70% in control group, the former was up-regulated significantly.
CONCLUSIONS: The expression of CKLF1 is up-regulated in atherosclerotic plaques. It may play an important role in the process of immune and inflammatory responses of atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20137403

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  1 in total

1.  Chemokine-like factor 1: A promising therapeutic target in human diseases.

Authors:  Xiaopeng Cai; Jingwen Deng; Qianqian Ming; Huiqiang Cai; Zhi Chen
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.